In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay - PubMed (original) (raw)

In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay

H Torres et al. Antimicrob Agents Chemother. 1993 Mar.

Abstract

The susceptibilities of 13 isolates of Coxiella burnetii to fusidic acid and ceftriaxone were determined by use of the recently described shell vial assay (D. Raoult, H. Torres, and M. Drancourt, Antimicrob. Agents Chemother, 35:2070-2077, 1991). At a concentration of 4 micrograms/ml, ceftriaxone was bacteriostatic for four isolates and slowed the multiplication of the other nine. Fusidic acid at a concentration of 2 micrograms/ml was bacteriostatic for six isolates and slowed the multiplication of three others. These results show that these compounds could be effective in the phagolysosome of C. burnetii-infected cells.

PubMed Disclaimer

Similar articles

• Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.
  Raoult D, Torres H, Drancourt M. Raoult D, et al. Antimicrob Agents Chemother. 1991 Oct;35(10):2070-7. doi: 10.1128/AAC.35.10.2070. Antimicrob Agents Chemother. 1991. PMID: 1759829 Free PMC article.
• Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
  Spyridaki I, Psaroulaki A, Vranakis I, Tselentis Y, Gikas A. Spyridaki I, et al. Antimicrob Agents Chemother. 2009 Jun;53(6):2690-2. doi: 10.1128/AAC.01424-08. Epub 2009 Mar 30. Antimicrob Agents Chemother. 2009. PMID: 19332671 Free PMC article.
• In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
  Gikas A, Spyridaki I, Psaroulaki A, Kofterithis D, Tselentis Y. Gikas A, et al. Antimicrob Agents Chemother. 1998 Oct;42(10):2747-8. doi: 10.1128/AAC.42.10.2747. Antimicrob Agents Chemother. 1998. PMID: 9756789 Free PMC article.
• Survival of the Q fever agent Coxiella burnetii in the phagolysosome.
  Baca OG, Li YP, Kumar H. Baca OG, et al. Trends Microbiol. 1994 Dec;2(12):476-80. doi: 10.1016/0966-842x(94)90651-3. Trends Microbiol. 1994. PMID: 7889323 Review.
• Life on the outside: the rescue of Coxiella burnetii from its host cell.
  Omsland A, Heinzen RA. Omsland A, et al. Annu Rev Microbiol. 2011;65:111-28. doi: 10.1146/annurev-micro-090110-102927. Annu Rev Microbiol. 2011. PMID: 21639786 Review.

Cited by

• Challenging case of chronic Q fever endocarditis: usefulness of 18F-FDG PET/CT in the diagnosis and follow-up.
  Markowich AH, Romani L, Leccisotti L, De Luca M. Markowich AH, et al. BMJ Case Rep. 2021 Aug 20;14(8):e243290. doi: 10.1136/bcr-2021-243290. BMJ Case Rep. 2021. PMID: 34417234 Free PMC article.
• Human metallo-β-lactamase enzymes degrade penicillin.
  Diene SM, Pinault L, Keshri V, Armstrong N, Khelaifia S, Chabrière E, Caetano-Anolles G, Colson P, La Scola B, Rolain JM, Pontarotti P, Raoult D. Diene SM, et al. Sci Rep. 2019 Aug 21;9(1):12173. doi: 10.1038/s41598-019-48723-y. Sci Rep. 2019. PMID: 31434986 Free PMC article.
• Current and past strategies for bacterial culture in clinical microbiology.
  Lagier JC, Edouard S, Pagnier I, Mediannikov O, Drancourt M, Raoult D. Lagier JC, et al. Clin Microbiol Rev. 2015 Jan;28(1):208-36. doi: 10.1128/CMR.00110-14. Clin Microbiol Rev. 2015. PMID: 25567228 Free PMC article. Review.
• Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection.
  Stein A, Louveau C, Lepidi H, Ricci F, Baylac P, Davoust B, Raoult D. Stein A, et al. Infect Immun. 2005 Apr;73(4):2469-77. doi: 10.1128/IAI.73.4.2469-2477.2005. Infect Immun. 2005. PMID: 15784593 Free PMC article.
• Q fever in Thailand.
  Suputtamongkol Y, Rolain JM, Losuwanaruk K, Niwatayakul K, Suttinont C, Chierakul W, Pimda K, Raoult D. Suputtamongkol Y, et al. Emerg Infect Dis. 2003 Sep;9(9):1186-7. doi: 10.3201/eid0909.030086. Emerg Infect Dis. 2003. PMID: 14531384 Free PMC article. No abstract available.

References

1. 1. Chemotherapy. 1986;32(2):102-12 - PubMed
2. 1. Antimicrob Agents Chemother. 1985 Jun;27(6):928-32 - PubMed
3. 1. Antimicrob Agents Chemother. 1986 Jan;29(1):182-3 - PubMed
4. 1. N Engl J Med. 1986 Nov 20;315(21):1358-9 - PubMed
5. 1. J Infect Dis. 1987 Mar;155(3):570-3 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations